Lymphadenectomy for lung carcinoids: Which factors may predict nodal upstaging? A multi centric, retrospective study.
lung carcinoid
lymphadenectomy
lymphnodes
upstaging
Journal
Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
revised:
06
04
2022
received:
11
11
2021
accepted:
23
04
2022
pubmed:
7
5
2022
medline:
2
8
2022
entrez:
6
5
2022
Statut:
ppublish
Résumé
To investigate risk factors for nodal upstaging in patients with lung carcinoids and to understand which type of lymphadenectomy is most appropriate. Data regarding patients with lung carcinoids, who underwent surgical resection and lymphadenectomy in five institutions from January 1, 2005 to December 31, 2019, were collected and retrospectively analyzed. Clinical and pathological tumor characteristics were correlated to analyze lymph node upstaging. The analysis was conducted on 283 patients. Pathology showed 230 typical and 53 atypical carcinoids. Nodal and mediastinal upstaging occurred in 33 (11.6%) and 16 (5.6%) patients, respectively. At the univariable analysis, nodal upstaging was significantly correlated with central location (p = 0.003), atypical histology (p < 0.001), pT dimension (p = 0.004), and advanced age (p = 0.043). The multivariable analysis confirmed atypical histology (odds ratio [OR]: 11.030; 95% confidence interval [CI]: 4.837-25.153, p < 0.001) and central location (OR: 3.295; 95% CI: 1.440-7.540, p = 0.005) as independent prognostic factors for nodal upstaging. Atypical histology (p < 0.001), pT dimension (p = 0.036), number of harvested lymph node stations (p = 0.047), and type of lymphadenectomy (p < 0.001) correlated significantly with mediastinal upstaging. The multivariable analysis confirmed atypical histology (OR: 5.408; 95% CI: 1.391-21.020, p = 0.015) and pT (OR: 1.052; 95% CI: 1.021-1.084, p = 0.001) as independent prognostic factors. Atypical histology, dimension, and central location are associated with a high-risk for occult hilo-mediastinal metastases, and mediastinal radical dissection may predict nodal upstaging. Thus, we suggest radical mediastinal lymph node dissection in high-risk tumors, reserving sampling, or lobe-specific dissection in peripheral, small typical carcinoids.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
588-598Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934-959.
Yao JC, Hassan M, Phan A, et al. One hundred years after “Carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Jclin Oncol. 2008;26:3063-3072.
Singh S, Bergsland EK, Card CM, et al. Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the diagnosis and management of patients with lung neuroendocrine tumors: an international collaborative endorsement and update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines. J Thorac Oncol. 2020;15(10):1577-1598. doi:10.1016/j.jtho.2020.06.021
Detterbeck F. Management of carcinoid tumors. Ann Thorac Surg. 2010;89:998-1005.
Kneuertz PJ, Kamel MK, Stiles BM, et al. Incidence and prognostic significance of carcinoid lymph node metastases. Ann Thorac Surg. 2018;106(4):981-988. doi:10.1016/j.athoracsur.2018.05.044
Filosso PL, Guerrera F, Evangelista A, et al. Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group. EurJCardiothorac Surg. 2015;48:441-447.
Filosso PL, Guerrera F, Falco NR, et al. Anatomical resections are superior to wedge resections for overall survival in patients with stage 1 typical carcinoids. Eur J Cardiothorac Surg. 2019;55(2):273-279. doi:10.1093/ejcts/ezy250
Cardillo G, Sera F, Di Martino M, et al. Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thorac Surg. 2004;77:1781-1785.
Daddi N, Schiavon M, Filosso PL, et al. Multi-Institutional Italian Pathology Group. Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids. Eur J Cardiothorac Surg. 2014;45(4):677-686. doi:10.1093/ejcts/ezt470
Cusumano G, Fournel L, Strano S, et al. Surgical resection for pulmonary carcinoid: long-term results of multicentric study-the importance of pathological N status, more than we thought. Lung. 2017;195(6):789-798. doi:10.1007/s00408-017-0056-8
Travis WD, Brambilla E, Mueller_Hermelink HK, Harris CC. Pathology and Genetics of Tumours of the Lung, Pleura,Thymus and Heart. IARC Press; 2004.
Lococo F, Rapicetta C, Mengoli MC, et al. Diagnostic performances of 68 Ga-DOTATOC versus 18 Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumours and interrelationship with histological features. Interact Cardiovasc Thorac Surg. 2019;28(6):957-960. doi:10.1093/icvts/ivz009
Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P. Members of IASLC Staging Committee. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4(5):568-577.
Lardinois D, De Leyn P, Van Schil P, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg. 2006;30(5):787-792. doi:10.1016/j.ejcts.2006.08.008
Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39-51. doi:10.1016/j.jtho.2015.09.009
Medbery RL, Gillespie TW, Liu Y, et al. Nodal upstaging is more common with thoracotomy than with VATS during lobectomy for early-stage lung cancer: an analysis from the national cancer data base. J Thorac Oncol. 2016;11(2):222-233.
Boffa DJ, Kosinski AS, Paul S, Mitchell JD, Onaitis M. Lymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resections. Ann Thorac Surg. 2012;94(2):347-353.
Chiappetta M, Leuzzi G, Sperduti I, et al. Mediastinal up-staging during surgery in non-small-cell lung cancer: which mediastinal lymph node metastasis patterns better predict the outcome? A multicenter analysis. Clin Lung Cancer. 2020;S1525-S7304(20):30082-30086. doi:10.1016/j.cllc.2020.03.004
Brown LM, Cooke DT, Jett JR, David EA. Extent of resection and lymph node assessment for clinical stage T1aN0M0 typical carcinoid tumors. Ann Thorac Surg. 2018;105(1):207-213. doi:10.1016/j.athoracsur.2017.07.049
Escalon J, Detterbeck F. Carcinoid tumors. In: Shields T, LoCicero JI, Reed C, Feins R, eds. General Thoracic Surgery. 7th ed. Lippincott Williams & Wilkins; 2009:1539-1554.
García-Yuste M, Matilla JM, Cueto A, et al. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish multi-centric study of neuroendocrine tumours of the lung. Eur J Cardiothorac Surg. 2007;31:192-197.
Westin GFM, Alsidawi S, Leventakos K, Halfdanarson TR, Molina JR. Impact of adjuvant chemotherapy in non-metastatic node positive bronchial neuroendocrine tumors (BNET). J Clin Oncol. 2017;35(15 suppl):8533.
Wegner RE, Abel S, Hasan S, et al. The role of adjuvant therapy for atypical bronchopulmonary carcinoids. Lung Cancer. 2019;131:90-94.
Chen X, Pang Z, Wang Y, et al. The role of surgery for atypical bronchopulmonary carcinoid tumor: development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database. Lung Cancer. 2020;139:94-102. doi:10.1016/j.lungcan.2019.11.006
Gosain R, Mukherjee S, Yendamuri SS, Iyer R. Management of typical and atypical pulmonary carcinoids based on different established guidelines. Cancers (Basel). 2018;12 10(12):510. doi:10.3390/cancers10120510
Chiappetta M, Sperduti I, Ciavarella LP, et al. Prognostic score for survival with pulmonary carcinoids: the importance of associating clinical with pathological characteristics. Interact Cardiovasc Thorac Surg. 2020;31(3):315-323. doi:10.1093/icvts/ivaa114
Benson RE, Rosado-de-Christenson ML, Martínez-Jiménez S, Kunin JR, Pettavel PP. Spectrum of pulmonary neuroendocrine proliferations and neoplasms. Radiographics. 2013;33:1631-1649.
Lococo F, Perotti G, Cardillo G, et al. Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid. Clin Nucl Med. 2015;40(3):e183-e189.
Chiappetta M, Rosella F, Dall'armi V, et al. CT-guided fine-needle ago-biopsy of pulmonary nodules: predictive factors for diagnosis and pneumothorax occurrence. Radiol Med. 2016;121(8):635-643. doi:10.1007/S11547-016-0639-0
Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 suppl):e142S-e1465.